Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alto Neuroscience

2.26
+0.01000.44%
Post-market: 2.25-0.0100-0.44%16:58 EDT
Volume:148.83K
Turnover:332.58K
Market Cap:61.18M
PE:-0.91
High:2.27
Open:2.19
Low:2.15
Close:2.25
Loading ...

Company Profile

Company Name:
Alto Neuroscience
Exchange:
NYSE
Establishment Date:
2019
Employees:
76
Office Location:
650 Castro Street,Suite 450,Mountain View,California,United States
Zip Code:
94041
Fax:
- -
Introduction:
Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD. In addition, the company develops novel pharmacodynamically synergistic combinations and an AI-enabled biomarker platform that combine sources of information on patients brain activity and behavior to identify patients to respond to novel product candidates. Alto Neuroscience, Inc. was incorporated in 2019 and is based in Los Altos, California.

Directors

Name
Position
Amit Etkin
President, Chief Executive Officer and Chair of the Board
Andrew Dreyfus
Director
Christopher Nixon Cox
Director
Gwill York
Director
Husseini Manji
Director
Po Yu Chen
Director

Shareholders

Name
Position
Amit Etkin
President, Chief Executive Officer and Chair of the Board
Fadi Abdel
Senior Vice President, Innovation
Nicholas Smith
Chief Financial Officer
Adam Savitz
Chief Medical Officer
Erin McQuade
General Counsel and Chief Administrative Officer
Jessica Powell
Chief Development Officer
Melissa Berman
Vice President, Finance and Accounting
Wei Wu
Chief Data Science Officer